Wanbangde Pharmaceutical Holding Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 332.63 million compared to CNY 582 million a year ago. Revenue was CNY 332.63 million compared to CNY 582 million a year ago. Net income was CNY 24.79 million compared to CNY 27.57 million a year ago. Basic earnings per share from continuing operations was CNY 0.04 compared to CNY 0.04 a year ago. Diluted earnings per share from continuing operations was CNY 0.04 compared to CNY 0.04 a year ago.